NCT00292838View on ClinicalTrials.gov

Relative Potency of Inhaled Corticosteroids

PHASE4CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions

AsthmaChronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

fluticasone 25, 50, 100, 200 mcg

Trial Locations (1)

L8N 4A6

Firestone Institute for Respiratory Health, St. Joseph's Healthcare, Hamilton

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

St. Joseph's Healthcare Hamilton

OTHER